The FDA application complements recent label extension submissions to the EMA and Health Canada, highlighting Valneva's strategic push to enhance IXCHIQ's global reach.
Valneva submits label extension application to US FDA for chikungunya vaccine, IXCHIQ: Saint Herblain, France Thursday, November 28, 2024, 16:00 Hrs [IST] Valneva SE, a specialty ...
We are in the early stages of the fall and winter respiratory virus season which brings up the important subject of pneumococcal vaccination. Pneumococcal vaccines, often called “pneumonia” vaccines, ...
Sixteen University of Otago – Ōtākou Whakaihu Waka researchers have received $2.8 million of Health Research Council funding to advance their careers. The mix of fellowships, and grants and ...
Fatal diseases like measles and Hepatitis B are on the rise in Germany, despite accessible vaccines. "Measles have come back to Germany," according to the country's top disease control center, the ...